Kv pharmaceuticals reported today that their sales of evamist are up 50% to 13.6 million.They stated that the sales were achieved on a reduced workforce due to their financial constraints.Lets hope that the product keeps ramping up.Ellavie in europe sales should be good as i am sure the current management will secure a much stronger financial partner than kv.
Add to My Watchlist
What is My Watchlist?